Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Nascobal to be commercialized outside U.S. for vitamin B12 deficiency

Oct. 28, 2010

MacroGenics and Pfizer enter into DART collaboration and license agreement

Oct. 28, 2010

Evotec and Apeiron Biologics collaborate on DREAM modulators for pain

Oct. 28, 2010

Celtic Therapeutics and Resolvyx Pharma form ophthalmology alliance

Oct. 27, 2010

Boehringer Ingelheim and MacroGenics to codevelop antibody-based therapeutics

Oct. 27, 2010

Pfizer gains exclusive global rights to commercialize several of Biocon's insulin products

Oct. 27, 2010

Cellectis and Kyoto University join forces for stem cell research

Oct. 26, 2010

NeuroVive and to-BBB to codevelop therapies for stroke and other CNS disorders

Oct. 26, 2010

Biogen Idec and Genentech amend collaboration agreement on CD20-targeting antibodies

Oct. 25, 2010

Depomed delivers prototype formulation of fixed-dose metformin/canagliflozin

Oct. 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...